Jason Andrade Presents Evidence Supporting Reduced Need for OAC Post-AF Ablation
Jason Andrade, Cardiologist at Vancouver Coastal Health, Elite Expert in Atrial Fibrillation, Co-chair of CCS, posted on X:
”In light of the recently published ALONE-AF trial, which tested the hypothesis that OAC discontinuation post ablation was a safe(r) strategy for patients I thought it would be good to review our recently larger meta-analysis on the topic.
In this analysis we examined 63 RCTs containing 11,161 patients
We found catheter ablation:
– Reduced the risk of stroke by 37% (7 less stroke per 1000 treated patients)
– Reduced the risk of death by 23% (16 less deaths per 1000 treated patients)
In conclusion, this large analysis of multiple RCTs shows that ablation reduces hard cardiovascular outcomes with high certainty.
Thus providing rationale for why OAC may not be necessary post ablation, as the risk of stroke is substantially reduced (eg 1.5% in OPTION, and 0.3-0.8% in ALONE-AF).”
Read the full study here.
Title: Catheter and Surgical Ablation for Atrial Fibrillation: A Systematic Review and Meta-analysis
Authors: Bryce Montané, Shiyang Zhang, Jonathan D. Wolfe, Sabrina Prime, Chongliang Luo, Daniel H. Cooper, Michelle Doering, Carina Blomstrom-Lundqvist, Samer A.M. Nashef, Pavel Osmancik, Jason G. Andrade, Emanuele Bertaglia, Ratika Parkash, Daniel B. Mark, Jens C. Nielsen, Linda D. Sharples, Brian F. Gage
Stay updated with Hemostasis Today.
-
Sep 12, 2025, 06:39Chokri Ben Lamine: Approach to Intra-Operative Bleeding in G6P Deficiency – Key Causes and Management
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 11, 2025, 08:32Rivaroxaban vs Apixaban in AFib and PAD - What the Data Say
-
Sep 11, 2025, 08:09Plasmin Activity and VTE Prevention․ Surprising Insights
-
Sep 10, 2025, 23:00Blood Vessels, Thrombosis and Hemostasis - Blood VTH and Blood Neoplasia: Now Indexed in PubMed!
-
Sep 12, 2025, 06:21Flora Peyvandi on Why Plasminogen Activation Is Not Required to Prevent Venous Thrombosis
-
Sep 12, 2025, 03:38Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
-
Sep 11, 2025, 15:03Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
-
Sep 11, 2025, 13:55Transplantation-Mediated Alloimmune Thrombocytopenia: Mostafa Faisal Mohammed Saleh Presents a Rare Case
-
Sep 11, 2025, 08:38Jason Andrade Presents Evidence Supporting Reduced Need for OAC Post-AF Ablation
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 11, 2025, 15:27Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
-
Sep 10, 2025, 19:32Denis Brutus Oduor: Call for Altruism in Blood Donation in Nairobi
-
Sep 10, 2025, 08:09Day 12 of Sickle Cell Awareness Month: Senabulya Muhammad Shares Reminder on Affordable Hemoglobin Testing in Uganda
-
Sep 9, 2025, 10:34James Douketis Receives the 2025 Distinguished Service Award in General Internal Medicine!